Cargando…

Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes

AIMS: This study aims to explore long‐term clinical outcomes of cardiopoiesis‐guided stem cell therapy for ischaemic heart failure assessed in the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial. METHODS AND RESULTS: CHART‐1 is a multinational, randomized, and double‐blin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartunek, Jozef, Terzic, Andre, Davison, Beth A., Behfar, Atta, Sanz‐Ruiz, Ricardo, Wojakowski, Wojciech, Sherman, Warren, Heyndrickx, Guy R., Metra, Marco, Filippatos, Gerasimos S., Waldman, Scott A., Teerlink, John R., Henry, Timothy D., Gersh, Bernard J., Hajjar, Roger, Tendera, Michal, Senger, Stefanie, Cotter, Gad, Povsic, Thomas J., Wijns, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754898/ https://www.ncbi.nlm.nih.gov/pubmed/33094909 http://dx.doi.org/10.1002/ehf2.13031

Ejemplares similares

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design
por: Bartunek, Jozef, et al.
Publicado: (2015)

Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
por: Bartunek, Jozef, et al.
Publicado: (2017)

Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome
por: Arrell, D. Kent, et al.
Publicado: (2020)

Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome
por: Arrell, D. Kent, et al.
Publicado: (2021)

Cardiopoietic programming of embryonic stem cells for tumor-free heart repair
por: Behfar, Atta, et al.
Publicado: (2007)

Optimized Catheter System Demonstrates Utility for Endomyocardial Delivery of Cardiopoietic Stem Cells in Target Patients With Heart Failure
por: Bartunek, Jozef, et al.
Publicado: (2023)

Clinical development plan for regenerative therapy in heart failure
por: Terzic, Andre, et al.
Publicado: (2016)

Mass Customized Outlook for Regenerative Heart Failure Care
por: Yamada, Satsuki, et al.
Publicado: (2021)

Endpoints in stem cell trials in ischemic heart failure
por: Banovic, Marko, et al.
Publicado: (2015)

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
por: Metra, Marco, et al.
Publicado: (2010)

Cardiomyocytes Derived from Human (Cardiopoietic)Amniotic Fluids
por: Di Baldassarre, Angela, et al.
Publicado: (2018)

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
por: Metra, Marco, et al.
Publicado: (2013)

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2014)

Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome—an analysis from RELAX-AHF
por: Voors, Adriaan A, et al.
Publicado: (2014)

Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study
por: Meyer, Sven, et al.
Publicado: (2016)

Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial
por: Biegus, Jan, et al.
Publicado: (2019)

Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy
por: Yamada, Satsuki, et al.
Publicado: (2019)

Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study (SEISMiC)
por: Metra, Marco, et al.
Publicado: (2022)

Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF
por: Davison, Beth A., et al.
Publicado: (2011)

Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2017)

Integrate and boost: bioscaffolds nurture the cardiac regenerative paradigm
por: Bartunek, Jozef, et al.
Publicado: (2015)

Regenerative heart failure therapy headed for optimization
por: Terzic, Andre, et al.
Publicado: (2014)

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study
por: Teerlink, John R., et al.
Publicado: (2017)

Relaxin: Review of Biology and Potential Role in Treating Heart Failure
por: Teichman, Sam L., et al.
Publicado: (2010)

Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF
por: Liu, Licette C. Y., et al.
Publicado: (2016)

Genomic chart guiding embryonic stem cell cardiopoiesis
por: Faustino, Randolph S, et al.
Publicado: (2008)

Vasodilators in the treatment of acute heart failure: what we know, what we don’t
por: Metra, Marco, et al.
Publicado: (2008)

Stem Cells in Cardiovascular Diseases: 30,000-Foot View
por: Povsic, Thomas J., et al.
Publicado: (2021)

Screening for regenerative therapy responders in heart failure
por: Yamada, Satsuki, et al.
Publicado: (2021)

Cardiogenic Induction of Pluripotent Stem Cells Streamlined Through a Conserved SDF-1/VEGF/BMP2 Integrated Network
por: Chiriac, Anca, et al.
Publicado: (2010)

Developmental Enhancement of Adenylate Kinase-AMPK Metabolic Signaling Axis Supports Stem Cell Cardiac Differentiation
por: Dzeja, Petras P., et al.
Publicado: (2011)

Relaxin, a pleiotropic vasodilator for the treatment of heart failure
por: Teichman, Sam L., et al.
Publicado: (2008)

Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial
por: Metra, Marco, et al.
Publicado: (2022)

Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure
por: Beldhuis, I. E., et al.
Publicado: (2023)

Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
por: van Essen, Bart J., et al.
Publicado: (2022)

Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head: mid-term update from a prospective study
por: Houdek, Matthew T., et al.
Publicado: (2021)

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
por: Teerlink, John R., et al.
Publicado: (2009)

Granulomatosis with polyangiitis presenting as ischaemic stroke
por: Davison, Rachel, et al.
Publicado: (2012)

Ranolazine inhibits shear sensitivity of endogenous Na(+) current and spontaneous action potentials in HL-1 cells
por: Strege, Peter, et al.
Publicado: (2012)

Reply to the Letter to the Editor: Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study
por: Houdek, Matthew T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pb6bav9qq1gnrllnkpe99jsgbb